Grazia Arpino

14PUBLICATIONS
112CO-AUTHORS
Tumour immunologyPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.

|Mar 06, 2026
Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Roberto Buonaiuto, Aldo Caltavituro, Rossana Di Rienzo

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Sep 13, 2025
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review.

Giuseppe Di Grazia, Arianna Dri, Angela Grieco

|Jul 01, 2025
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER).

Carmine De Angelis, Martina Pagliuca, Emanuela Magnolfi

|May 14, 2025
Cardio-Oncology Challenges in Elderly Patients.

Ester Topa, Eliana De Rosa, Alessandra Cuomo

Pageof 3

Frequent Collaborators

7 joint publications

Lucia Del Mastro

5 joint publications

Fabio Puglisi

3 joint publications

Michela Palleschi

2 joint publications

Filippo Montemurro